Tubigon, Jesse .
HRN: 25-94-93 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/27/2024
CLINDAMYCIN 150MG/ML, 4ML (AMP)
09/27/2024
10/04/2024
IV
600MG
Q6
CELLULITIS
Waiting Final Action
Indication: Empiric Type of Infection: Skin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes